Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling

Vince T. Nguyen, Yewen Wu, Ashley Guillory, Bradley K. McConnell, Kenichi Fujise, Ming He Huang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cardiac epinephrine and calcitonin gene-related peptide (CGRP) are produced by intrinsic cardiac adrenergic cells (ICA cells) residing in human and animal hearts. ICA cells are neuroparicine cells expressing δ-opioid receptors (DOR). We hypothesized that δ-opioid stimulation of ICA cells enhances epinephrine and CGRP release, which results in the augmentation of heart contraction. Rats were injected with DOR-agonist DPDPE (100 μg/kg) with or without 10-min pretreatment with either β-adrenergic receptor (β-AR) blocker propranolol (2 mg/kg) or CGRP-receptor (CGRPR) blocker CGRP 8-37 (300 μg/kg), or their combination. Hemodynamics were monitored with echocardiogram and systolic blood pressure (SBP) was monitored via a tail arterial catheter. Changes in left ventricular fraction-shortening (LVFS) and heart rate (HR) were observed at 5-min after DPDPE infusion. At 5-min DPDPE induced a 36 ± 18% (p < 0.001) increase of the LVFS, which continues to increase to 51 ± 24% (p < 0.0001) by 10 min, and 68 ± 19% (p < 0.001) by 20 min. The increase in LVFS was accompanied by the decrease of HR by 9 ± 5% (p < 0.01) by 5 min and 11 ± 6% (p < 0.001) by 15 min post DPDPE infusion. This magnitude of HR reduction was observed for the remainder of the 20 min. Despite the HR-reduction, cardiac output was increased by 17 ± 8% (p < 0.05) and 28 ± 5% (p < 0.001) by 5- and 20-min post DPDPE administration, respectively. There was a modest (9 ± 9%, p = 0.03) decrease in SBP that was not apparent until 20 min post DPDPE infusion. The positive inotropism of DPDPE was abrogated in animals pretreated with propranolol, CGRP 8-37, or combined propranolol + CGRP 8-37. Furthermore, in whole animal and cardiomyocyte cell culture preparations, DPDPE induced myocardial protein-kinase A (PKA) activation which was abrogated in the animals pretreated with propranolol + CGRP 8-37. DOR agonists augment myocardial contraction through enhanced β-AR and CGRPR co-signaling.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalPeptides
Volume33
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

D-Penicillamine (2,5)-Enkephalin
Calcitonin Gene-Related Peptide Receptors
Adrenergic Agents
Opioid Analgesics
Propranolol
Animals
Heart Rate
Blood Pressure
Calcitonin Gene-Related Peptide
Blood pressure
Epinephrine
Myocardial Contraction
Adrenergic Antagonists
Catheters
Hemodynamics
Opioid Receptors
Muscle Contraction
Cyclic AMP-Dependent Protein Kinases
Cell culture
Cardiac Myocytes

Keywords

  • δ-Opioid receptor
  • Contractility
  • Heart
  • ICA cell

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling. / Nguyen, Vince T.; Wu, Yewen; Guillory, Ashley; McConnell, Bradley K.; Fujise, Kenichi; Huang, Ming He.

In: Peptides, Vol. 33, No. 1, 01.2012, p. 77-82.

Research output: Contribution to journalArticle

Nguyen, Vince T. ; Wu, Yewen ; Guillory, Ashley ; McConnell, Bradley K. ; Fujise, Kenichi ; Huang, Ming He. / Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling. In: Peptides. 2012 ; Vol. 33, No. 1. pp. 77-82.
@article{ae87dcab51014f458eeedd80e0de5855,
title = "Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling",
abstract = "Cardiac epinephrine and calcitonin gene-related peptide (CGRP) are produced by intrinsic cardiac adrenergic cells (ICA cells) residing in human and animal hearts. ICA cells are neuroparicine cells expressing δ-opioid receptors (DOR). We hypothesized that δ-opioid stimulation of ICA cells enhances epinephrine and CGRP release, which results in the augmentation of heart contraction. Rats were injected with DOR-agonist DPDPE (100 μg/kg) with or without 10-min pretreatment with either β-adrenergic receptor (β-AR) blocker propranolol (2 mg/kg) or CGRP-receptor (CGRPR) blocker CGRP 8-37 (300 μg/kg), or their combination. Hemodynamics were monitored with echocardiogram and systolic blood pressure (SBP) was monitored via a tail arterial catheter. Changes in left ventricular fraction-shortening (LVFS) and heart rate (HR) were observed at 5-min after DPDPE infusion. At 5-min DPDPE induced a 36 ± 18{\%} (p < 0.001) increase of the LVFS, which continues to increase to 51 ± 24{\%} (p < 0.0001) by 10 min, and 68 ± 19{\%} (p < 0.001) by 20 min. The increase in LVFS was accompanied by the decrease of HR by 9 ± 5{\%} (p < 0.01) by 5 min and 11 ± 6{\%} (p < 0.001) by 15 min post DPDPE infusion. This magnitude of HR reduction was observed for the remainder of the 20 min. Despite the HR-reduction, cardiac output was increased by 17 ± 8{\%} (p < 0.05) and 28 ± 5{\%} (p < 0.001) by 5- and 20-min post DPDPE administration, respectively. There was a modest (9 ± 9{\%}, p = 0.03) decrease in SBP that was not apparent until 20 min post DPDPE infusion. The positive inotropism of DPDPE was abrogated in animals pretreated with propranolol, CGRP 8-37, or combined propranolol + CGRP 8-37. Furthermore, in whole animal and cardiomyocyte cell culture preparations, DPDPE induced myocardial protein-kinase A (PKA) activation which was abrogated in the animals pretreated with propranolol + CGRP 8-37. DOR agonists augment myocardial contraction through enhanced β-AR and CGRPR co-signaling.",
keywords = "δ-Opioid receptor, Contractility, Heart, ICA cell",
author = "Nguyen, {Vince T.} and Yewen Wu and Ashley Guillory and McConnell, {Bradley K.} and Kenichi Fujise and Huang, {Ming He}",
year = "2012",
month = "1",
doi = "10.1016/j.peptides.2011.11.010",
language = "English (US)",
volume = "33",
pages = "77--82",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling

AU - Nguyen, Vince T.

AU - Wu, Yewen

AU - Guillory, Ashley

AU - McConnell, Bradley K.

AU - Fujise, Kenichi

AU - Huang, Ming He

PY - 2012/1

Y1 - 2012/1

N2 - Cardiac epinephrine and calcitonin gene-related peptide (CGRP) are produced by intrinsic cardiac adrenergic cells (ICA cells) residing in human and animal hearts. ICA cells are neuroparicine cells expressing δ-opioid receptors (DOR). We hypothesized that δ-opioid stimulation of ICA cells enhances epinephrine and CGRP release, which results in the augmentation of heart contraction. Rats were injected with DOR-agonist DPDPE (100 μg/kg) with or without 10-min pretreatment with either β-adrenergic receptor (β-AR) blocker propranolol (2 mg/kg) or CGRP-receptor (CGRPR) blocker CGRP 8-37 (300 μg/kg), or their combination. Hemodynamics were monitored with echocardiogram and systolic blood pressure (SBP) was monitored via a tail arterial catheter. Changes in left ventricular fraction-shortening (LVFS) and heart rate (HR) were observed at 5-min after DPDPE infusion. At 5-min DPDPE induced a 36 ± 18% (p < 0.001) increase of the LVFS, which continues to increase to 51 ± 24% (p < 0.0001) by 10 min, and 68 ± 19% (p < 0.001) by 20 min. The increase in LVFS was accompanied by the decrease of HR by 9 ± 5% (p < 0.01) by 5 min and 11 ± 6% (p < 0.001) by 15 min post DPDPE infusion. This magnitude of HR reduction was observed for the remainder of the 20 min. Despite the HR-reduction, cardiac output was increased by 17 ± 8% (p < 0.05) and 28 ± 5% (p < 0.001) by 5- and 20-min post DPDPE administration, respectively. There was a modest (9 ± 9%, p = 0.03) decrease in SBP that was not apparent until 20 min post DPDPE infusion. The positive inotropism of DPDPE was abrogated in animals pretreated with propranolol, CGRP 8-37, or combined propranolol + CGRP 8-37. Furthermore, in whole animal and cardiomyocyte cell culture preparations, DPDPE induced myocardial protein-kinase A (PKA) activation which was abrogated in the animals pretreated with propranolol + CGRP 8-37. DOR agonists augment myocardial contraction through enhanced β-AR and CGRPR co-signaling.

AB - Cardiac epinephrine and calcitonin gene-related peptide (CGRP) are produced by intrinsic cardiac adrenergic cells (ICA cells) residing in human and animal hearts. ICA cells are neuroparicine cells expressing δ-opioid receptors (DOR). We hypothesized that δ-opioid stimulation of ICA cells enhances epinephrine and CGRP release, which results in the augmentation of heart contraction. Rats were injected with DOR-agonist DPDPE (100 μg/kg) with or without 10-min pretreatment with either β-adrenergic receptor (β-AR) blocker propranolol (2 mg/kg) or CGRP-receptor (CGRPR) blocker CGRP 8-37 (300 μg/kg), or their combination. Hemodynamics were monitored with echocardiogram and systolic blood pressure (SBP) was monitored via a tail arterial catheter. Changes in left ventricular fraction-shortening (LVFS) and heart rate (HR) were observed at 5-min after DPDPE infusion. At 5-min DPDPE induced a 36 ± 18% (p < 0.001) increase of the LVFS, which continues to increase to 51 ± 24% (p < 0.0001) by 10 min, and 68 ± 19% (p < 0.001) by 20 min. The increase in LVFS was accompanied by the decrease of HR by 9 ± 5% (p < 0.01) by 5 min and 11 ± 6% (p < 0.001) by 15 min post DPDPE infusion. This magnitude of HR reduction was observed for the remainder of the 20 min. Despite the HR-reduction, cardiac output was increased by 17 ± 8% (p < 0.05) and 28 ± 5% (p < 0.001) by 5- and 20-min post DPDPE administration, respectively. There was a modest (9 ± 9%, p = 0.03) decrease in SBP that was not apparent until 20 min post DPDPE infusion. The positive inotropism of DPDPE was abrogated in animals pretreated with propranolol, CGRP 8-37, or combined propranolol + CGRP 8-37. Furthermore, in whole animal and cardiomyocyte cell culture preparations, DPDPE induced myocardial protein-kinase A (PKA) activation which was abrogated in the animals pretreated with propranolol + CGRP 8-37. DOR agonists augment myocardial contraction through enhanced β-AR and CGRPR co-signaling.

KW - δ-Opioid receptor

KW - Contractility

KW - Heart

KW - ICA cell

UR - http://www.scopus.com/inward/record.url?scp=84855803092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855803092&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2011.11.010

DO - 10.1016/j.peptides.2011.11.010

M3 - Article

VL - 33

SP - 77

EP - 82

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 1

ER -